SUMMARY Two glycine supplemented oral rehydration solutions (ORS) and a standard ORS with sodium 60 mmol/I were compared for treatment of diarrhoeal dehydration in children. The solutions contained glycine 110 mmolI and glucose 110 mmol/I (ORS60-Gly1l0), glycine 60 mmoL/l and glucose 80 mmoL/l (ORS60-Gly6o), and glucose 144 mmolI only (ORS60), respectively. The patients receiving ORS60-Glyl1o had poor weight gain and increased stool and urine volumes after rehydration compared with the other two groups. The patients receiving ORS60-Gly6o had similar stool and urine volumes as those receiving standard ORS60. It is concluded that excess glycine in relation to sodium in an ORS may lead to osmotic diarrhoea, and a high amount of absorbed glycine may result in osmotic diuresis with poor net rehydration. Altogether, the present study failed to find any improvement ('Super-ORS') by addition of glycine to an ORS containing 60 mmoL/l of sodium.
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Oral rehydration solution with the composition recommended by the World Health Organisation (WHO) (sodium 90 mmol/l, glucose 111 mmol/l, ORS-WHO) has proved to be highly successful for the correction of dehydration associated with diarrhoea of diverse ongin.' There is evidence, however, that modifications in the composition of ORS-WHO may further enhance water absorption in the intestines and improve rehydration.2 4 Addition of amino acids or dipeptides to ORS-WHO has been suggested and experimented with,2 3 as many amino acids, such as glycine, stimulate sodium coupled water absorption from the gut independently from glucose. ' Thus the study was randomised but not double blind-that is, the rehydration solutions were not code labelled. In the course of the trial it became 372 apparent that some patients receiving ORS60-Gly,10
were not responding well, and we decided to reduce the glycine concentration and total osmolality of the solution, and ORS6o-Gly60 replaced ORS60-Glyllo.
Since the introduction of ORS60-Gly60 three quarters of the admitted patients were randomised to receive this solution and one quarter ORS60. The total numbers of patients in each group were 18 in the group treated with ORS60-Glyllo, 16 in the group treated with ORS60-Gly60, and 22 in the group treated with ORS60.
The compositions of the three solutions are presented in Table 1 The patients were examined on admission by the paediatrician on duty, and the decision to admit the patient to hospital was made by clinical judgment. The degree (%) of dehydration was estimated on admission using available information of the patient's preadmission weight and clinical signs. 'Acute weight loss' was calculated as the difference between the actual weight and the expected weight of the child as taken from his or her growth chart, and this was then used as a basis of rehydration therapy. The amount of fluid to be administered was 2x2/3x acute weight loss within six hours. Between six and 12 hours after the beginning of treatment the same ORS was given as maintenance fluid, the amount being 1/4 of the 24 hour need of water calculated from the standard formula: 100 ml/kg up to 10 kg of body weight, 50 ml/kg between 10 and 20 kg of body weight, and 20 ml/kg over 20 kg. From 12 hours on an attempt was made to introduce a full normal diet for age, including normal drink.
Blood specimens were collected on admission and six, 12, and 24 hours after the beginning of treatment for the determination of serum electrolytes and total plasma protein concentrations, blood acid-base analysis, and packed cell volume. Urine The presence of rotavirus in stools was shown with an enzyme immunoassay (Rotazyme II, Abbott Laboratories). The stools were also cultured for salmonella, shigella, yersinia, and campylobacter, but none of these enteropathogens were discovered.
The study protocol was reviewed and approved by the hospital's ethical committee. Statistical calculations were performed using the statistical data processing system of the University of Tampere.
Results
The groups of patients receiving each of the three oral rehydration solutions were easily comparable (Table 2 ), but the mean dehydration percentage was greater in the standard ORS60 group than in the other two groups. This difference was reflected in the amounts of fluid that the patients actually received in the first six hours ( Table 3 ). The amounts of each ORS given within the first six hours corresponded closely to the original plan of 2X2/3x acute weight loss-that is, the treatment could be carried out as planned in all the patients. A nasogastric tube was commonly used: 12 children in the ORS60-Glyllo group, 11 in the ORS60-Gly60, and 13 in the ORS60 group were given at least part of the required amount through a nasogastric tube.
The children who received the standard ORS60 responded to treatment as expected on the basis of our previous experience. They showed good weight gain in the first 12 hours (Table 3) , and the total duration of watery diarrhoea remained short ( Table  4) . Reintroduction of feedings was generally successful, the initial weight gain was maintained, and total time in hospital remained short (Tables 3   and 4 ). Two patients received supportive intravenous fluids, started on the second day of admission for continuous diarrhoea.
In contrast to the standard ORS60 group, the group receiving ORS60-Glyl10 showed a poor weight gain in the first 12 hours (Table 3 ). The volume of stools was also somewhat (but not significantly) larger than in the ORS60 group (Table 3) , as was the duration of watery diarrhoea (Table 4) . Moreover, (Tables 3 and 4 ).
The mean weight gain at 12 hours in the ORS60-Gly6o group was less than in the ORS60 group, but this could partly be explained by the lower degree of initial dehydration and smaller volume of ORS given (Tables 2 and 3 ). The urine and stool volumes in the two groups were quite similar in the follow up period (Table 3 ). In one case of the 16 in the ORS60-Gly6o group rehydration after six hours was considered inadequate and one child was transferred to intravenous treatment; one more child received 'supportive' intravenous fluids at a later time. Rehydration was also measured by packed cell volume, total plasma protein concentrations, and blood acid-base analysis during rehydration at six, 12, and 24 hours after treatment (data not shown). As the initial dehydration was only mild to moderate it was not possible to detect appreciable differences in the rehydration rate between the groups using these indicators. The children receiving ORS60-Glyllo tended to remain more acidotic at 12 and 24 hours of treatment than children in the other two groups, but the difference was not significant.
The calculated sodium input in the first six and 12 hours of treatment and the corresponding urinary excretions up to 24 hours are shown in Table 3 . The urinary sodium excretion in the ORS60-Glyll0 group was higher than in the other two groups throughout that period. In the ORS60-Gly60 group the mean sodium excretion was also slightly higher than in the ORS6o group. In the latter group urinary sodium excretion remained low up to 24 hours, indicating that most of the sodium input was used for replacing sodium deficit. The serum sodium concentrations remained unchanged in all three groups during rehydration (data not shown). There were no changes in serum potassium or chloride concentrations either.
The daily weight changes in all three groups are presented in Table 3 , and the overall weight gain by the time of discharge in Table 4 . In general, the initial weight gain after rehydration was maintained in all groups, and the differences between groups remained similar throughout the hospital stay.
Discussion
The present experience with glycine in an oral rehydration solution containing 60 mmolI sodium was not very encouraging as glycine seemed to cause osmotic diarrhoea and diuresis, or both. Initially, our research was prompted by the findings of Patra et al, who showed that an ORS of the WHO formula supplemented with 111 mmol/l of glycine was more effective than ordinary ORS-WHO for treatment of acute diarrhoeal dehydration.2 It is therefore necessary to search for explanations for the apparently different experience.
The sodium concentration in our solutions was intentionally kept at 60 mmol/l as we believe this should be sufficient for an 'all purpose' (outpatient and inpatient) oral rehydration solution in our conditions where most of the patients with acute diarrhoea are likely to be mildly to moderately dehydrated with normal serum sodium concentrations.8 Thus the glycine:sodium ratio in the first glycine supplemented solution, ORS60-Glyllo, was not optimal as it is known that the molar ratio for best net absorption should be roughly 1:1.5 Excess glycine in the slightly hypertonic solution could conceivably cause osmotic penalty, resulting in increased stool volume, as was observed in the patient group receiving ORS60-Glyllo. However, osmotic diarrhoea and somewhat larger stool volume in the first 48 hours does not seem to be a sufficient explanation for the poor weight gain in these children. The same children also had significantly greater urine volume between 12 and 24 hours, suggesting that most of the ORS60-Glyllo solution was actually absorbed but part of the absorbed fluid was later excreted in urine. A probable mechanism might be excretion of excess glycine in the urine with resulting osmotic diuresis. Unfortunately, we did not measure urinary excretion of glycine directly. When in the second solution, ORS6,-Gly6,, the quantity of glycine was reduced (to a molar ratio 1:1 with sodium) no such increase in urine volume was seen despite the fact that the solution was apparently well absorbed.
Different aetiology of diarrhoea in our patients and those of Patra et al3 could also be responsible for the different experience of the glycine supplemented ORS. Most of our patients had rotavirus diarrhoea, whereas the patients of Patra et al in India had predominantly secretory diarrhoea due to Vibrio cholerae or Escherichia coli. 3 The absorption of glycine could differ in diarrhoeas of different pathogenetic mechanism. In toxigenic secretory diarrhoea the gut epithelium remains intact, and the absorption is effective throughout the length of the small intestine. In contrast, in rotavirus diarrhoea there is structural damage, particularly in the proximal small intestine, where glycine absorption is supposed to take place. Thus it is possible that glycine absorption is reduced in rotavirus but not in toxigenic diarrhoea, whereas glucose might be equally effective as a carrier for sodium coupled water absorption in both conditions. Furthermore, rotavirus infection might cause more metabolic stress than secretory diarrhoea due to E. coli, and utilisation of glycine in the body could then be less effective in rotavirus diarrhoea. Under such a catabolic effect excess glycine would be excreted.
Another methodological difference between the studies was that we gave only a precalculated amount of ORS for rapid rehydration to all the patients, whereas Patra et Con- sidering the present experience it will be of great importance to test any such experimental solution in the actual patient population, which in our conditions means young children with rotavirus diarrhoea.
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